Amosulalol HCl

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329318

CAS#: 93633-92-2 ( HCl)

Description: Amosulalol Hydrochloride, also known as Lowgan and YM-09538, is an alpha- and beta-adrenergic receptor antagonist used to treat hypertension.

Chemical Structure

img
Amosulalol HCl
CAS# 93633-92-2 ( HCl)
Instruction

Theoretical Analysis

MedKoo Cat#: 329318
Name: Amosulalol HCl
CAS#: 93633-92-2 ( HCl)
Chemical Formula: C18H25ClN2O5S
Exact Mass: 416.12
Molecular Weight: 416.917
Elemental Analysis: C, 51.86; H, 6.04; Cl, 8.50; N, 6.72; O, 19.19; S, 7.69

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 85320-68-9 (free base)   93633-92-2 ( HCl)    

Synonym: Amosulalol Hydrochloride; YM-09538; YM 09538; YM09538; Lowgan

IUPAC/Chemical Name: 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methylbenzenesulfonamide hydrochloride

InChi Key: JRVCPDVOFCWKAG-UHFFFAOYSA-N

InChi Code: InChI=1S/C18H24N2O5S.ClH/c1-13-7-8-14(11-18(13)26(19,22)23)15(21)12-20-9-10-25-17-6-4-3-5-16(17)24-2;/h3-8,11,15,20-21H,9-10,12H2,1-2H3,(H2,19,22,23);1H

SMILES Code: O=S(C1=C(C)C=CC(C(O)CNCCOC2=CC=CC=C2OC)=C1)(N)=O.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info: Related CAS# 85320-68-9 (Amosulalol) 93633-92-2 (Amosulalol Hydrochloride)

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 416.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Jin WL, Azuma K, Mita T, Goto H, Kanazawa A, Shimizu T, Ikeda F, Fujitani Y, Hirose T, Kawamori R, Watada H. Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta. Diabetologia. 2011 Jul;54(7):1921-9. doi: 10.1007/s00125-011-2141-5. Epub 2011 Apr 16. PubMed PMID: 21499675.

2: Suzuki K, Kamimura H. Pharmacokinetics and metabolism of an alpha,beta-blocker, amosulalol hydrochloride, in mice: biliary excretion of carbamoyl glucuronide. Biol Pharm Bull. 2007 Aug;30(8):1580-5. PubMed PMID: 17666826.

3: Gwak HS, Noh ES, Lee NY, Chun IK. Determination of amosulalol in human plasma using solid-phase extraction combined with liquid chromatography and ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Apr 25;818(2):109-13. PubMed PMID: 15734149.

4: Ueyama T, Aki T, Senba E, Hatanaka K, Yoshida K. Emotional stress activates MAP kinase in the rat heart. Life Sci. 2001 Sep 7;69(16):1927-34. PubMed PMID: 11693273.

5: Nakamura T, Maruyama K, Ohnuki T, Hattori K, Watanabe K, Nagatomo T. Tamsulosin: assessment of affinityof (3)H-P razosin binding to two alpha-1- adrenoceptor subtypes in the canine aorta. Pharmacology. 1999 Nov;59(5):234-8. PubMed PMID: 10529655.

6: Tamaki Y, Araie M, Muta K. Effect of topical amosulalol on tissue circulation in the optic nerve head. J Ocul Pharmacol Ther. 1999 Jun;15(3):217-24. PubMed PMID: 10385130.

7: Maruyama K, Nakamura T, Yoshihara T, Fukutomi J, Sugiyama K, Hattorim K, Ohnuki T, Watanabe K, Nagatomo T. Tamsulosin: assessment of affinity of 3H-prazosin bindings to two alpha1-adrenoceptor subtypes (alpha1H and alpha1L) in bovine prostate and rat heart and brain. Gen Pharmacol. 1998 Oct;31(4):597-600. PubMed PMID: 9792222.

8: Takada S, Numabe A, Hirawa N, Yagi S, Uehara Y. Thromboxane inhibition potentiates antihypertensive effects of alpha 1 adrenoceptor antagonists in the rat. Prostaglandins Leukot Essent Fatty Acids. 1997 Feb;56(2):127-34. PubMed PMID: 9051722.

9: Taniguchi T, Deguchi T, Ogawa T, Kitazawa Y. [Effects of amosulalol hydrochloride on intraocular pressure and aqueous humor dynamics in the rabbit eye]. Nippon Ganka Gakkai Zasshi. 1996 Apr;100(4):279-83. Japanese. PubMed PMID: 8644539.

10: Asakuma S, Ohyanagi M, Iwasaki T. The effects of antianginal drugs on energy expenditure during exercise in normal subjects. Jpn Circ J. 1995 Mar;59(3):137-45. PubMed PMID: 7602749.

11: Inagaki O, Sudoh K, Shibasaki M, Nakagawa C, Honda K. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats. J Cardiovasc Pharmacol. 1994 Nov;24(5):794-802. PubMed PMID: 7532758.

12: van Zwieten PA. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists. Drugs. 1993 Apr;45(4):509-17. Review. PubMed PMID: 7684671.

13: Hayase N, Chiba K, Ichihara K. Effects of amosulalol, a combined alpha 1- and beta-adrenoceptor-blocking agent, on ischemic myocardial energy metabolism in dogs. J Pharm Sci. 1993 Mar;82(3):291-5. PubMed PMID: 8095542.

14: Kinami J, Tsuchihashi H, Maruyama K, Sasaki K, Nagatomo T. Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes. Jpn J Pharmacol. 1993 Feb;61(2):81-6. PubMed PMID: 7681491.

15: Doggrell SA. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein. Chirality. 1993;5(1):8-14. PubMed PMID: 8095397.

16: Ando K, Noda H, Ogata E, Fujita T. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension. J Cardiovasc Pharmacol. 1992 Jul;20(1):7-10. PubMed PMID: 1383633.

17: Inoue Y, Yaga K, Nishimura M, Okafuji K, Fujii Y, Nagasaka Y, Tanaka M, Fujita N, Kaku K, Kaneko T, et al. Antihypertensive and metabolic effects of long-term treatment with amosulalol in non-insulin dependent diabetics. Curr Med Res Opin. 1992;12(9):564-71. PubMed PMID: 1582238.

18: Tanaka S, Miyabe M, Ohyama I, Seki S, Tsukamoto T, Namiki A. [Sevoflurane with continuous epidural anesthesia for removal of pheochromocytoma]. Masui. 1991 Aug;40(8):1261-4. Japanese. PubMed PMID: 1920806.

19: Yamaguchi T, Irisawa C, Watanabe H, Kawamura S, Nakada T. Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma. Int Urol Nephrol. 1991;23(3):209-14. PubMed PMID: 1889965.

20: Strein K, Sponer G. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule. Z Kardiol. 1990;79 Suppl 3:89-98. Review. PubMed PMID: 1983054.